Combined Treatment with Pravastatin and Gemfibrozil in Patients with Refractory Familial Combined Hyperlipidaemia
- 1 March 1994
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 7 (3) , 134-142
- https://doi.org/10.1007/bf03258465
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)The American Journal of Cardiology, 1992
- Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performanceClinical Cardiology, 1992
- Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.BMJ, 1992
- Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levelsJournal of Internal Medicine, 1990
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Biochemical, clinical, genetic and metabolic studies of hyperapo-β-lipoproteinaemiaJournal of Inherited Metabolic Disease, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaThe American Journal of Cardiology, 1986
- Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A MetabolismJournal of Clinical Investigation, 1979